26 March
2024
Xaar
plc
2023
FULL YEAR RESULTS
STRATEGIC PROGRESS AND WELL POSITIONED FOR MEDIUM &
LONG-TERM OPPORTUNITY
Xaar plc ("Xaar", the "Group" or
the "Company"), the leading inkjet printing technology group, today
announces its full year results for the 12 months ended 31 December
2023.
Financial Summary:
|
2023
|
2022
|
Change
|
Revenue
|
£70.6m
|
£72.8m
|
-3%
|
Gross profit
|
£26.9m
|
£28.6m
|
-6%
|
Gross margin %
|
38%
|
39%
|
-1ppt
|
R&D spend
|
£5.6m
|
£6.7m
|
-17%
|
Adjusted
EBITDA1
|
£6.4m
|
£6.2m
|
3%
|
Adjusted profit before
tax2
|
£2.9m
|
£2.8m
|
+4%
|
(Loss)/Profit before tax
|
(£2.4m)
|
£0.8m
|
|
(Loss)/Profit for the
year
|
(£2.2m)
|
£1.8m
|
|
|
|
|
|
Basic (loss)/earnings per
share
|
(2.8p)
|
2.1p
|
|
|
|
|
|
Net cash at the year
end3
|
£7.1m
|
£8.5m
|
|
1 -
EBITDA is calculated as statutory operating profit before
depreciation (other than that arising from IFRS 16 lease
accounting), amortisation and impairment of property, plant and
equipment, intangible assets and goodwill. Adjusted EBITDA is
calculated as EBITDA excluding Adjusting Items listed in Note 2
below.
2 - Excluding the
impact of share-based payment charges, exchange gains or losses on
intra-group transactions, restructuring and transaction
expenses, research and development expenditure tax credits,
fair value losses on financial assets at fair value through
profit and loss, and amortisation of intangible assets arising on
business combinations
3 - Net cash at 31 December includes
cash, cash equivalents and treasury deposits
Financial Highlights
·
Revenue of £70.6 million (2022: £72.8 million)
with increased customer adoption of our technology
·
Gross margin of 38% benefitting from actions to
mitigate input cost increases and increased operational
leverage
·
R&D spend of £5.6 million, equating to 8% of
Group Revenue, underscores the continued investment in the product
roadmap, with a focus on the ImagineX platform
·
Adjusted Group profit for the year of £2.9
million in line with Board expectations
·
Healthy balance sheet with net cash of £7.1
million
Strategic and Operational Highlights
·
Increasing number of customers in development and
enhanced relationships with end customers, giving rise to
additional product launches expected in 2024 and anticipated
recovery in key markets
·
Further operational progress made in
Engineered Printing Solutions (EPS),
delivering strong revenue growth and good performances from FFEI
and Megnajet
·
Phase 1 of operational efficiency programme
complete with factory re-organisation delivered on time and under
budget delivering cost savings and increased capacity
·
Cost reduction plan in place to navigate current
market conditions
·
Investment in working capital ensured successful
mitigation of supply chain constraints as well as meeting customer
demand
John Mills, Chief Executive Officer,
commented:
"Whilst the external trading environment remains challenging,
we have a clear plan in place and remain focused on the delivery of
our strategy and taking advantage of the significant opportunities
we have that will drive profitable growth. Our products continue to
generate strong interest from customers, demonstrating our
leadership in printing highly viscous fluids with all the
performance and sustainability benefits they
deliver.
Due to the current market conditions, adoption of our
customers' products is taking longer than expected, impacting our
revenue, however, we have put in place a cost action plan to
mitigate this. We remain optimistic about the future, being well
placed to benefit as the trading environment
improves.
With a substantial market opportunity and the progress made,
we remain well positioned to realise our exciting
potential."
Contacts:
Xaar plc
|
|
Ian Tichias, Chief Financial
Officer
|
+44 (0) 1223 423
663
|
John Mills, Chief Executive
Officer
|
|
Teneo
|
+44 (0) 207 353 4200
|
Giles Kernick
Olivia Lucas
|
|
A presentation for analysts and
investors will be held via webcast and conference call at 09:00
today. For further details, please contact
Xaar@teneo.com
Chairman's Statement
2023 was a challenging year.
Despite a strong start, the impact of macro-economic and
geo-political factors slowed the momentum the business was
building, particularly so in the fourth quarter. Global inflation
and higher interest rates have led to lower demand for capital
goods, and this has had an impact on our revenues.
Overall financial performance in
2023 was broadly in line with the Board's expectations with trading
conditions being relatively weak, particularly in China, which is
an important market for the business. In the latter part of the
year, it also became clear that some customers were responding to
general market conditions and geo-political events by delaying
their new product launch plans, resulting in less certainty in the
timing of new business for Xaar. Several customer product launches
anticipated to take place at the end of 2023 and early in 2024 are
now expected in mid to late 2024.
Despite these external challenges,
good progress has been made within the business as our technology
and product programme continue to deliver new capabilities and
enhanced performance. Our High Viscosity technology is creating
significant interest across a number of markets, and we are pleased
to be developing strong partnerships with leading suppliers in
sectors that represent new application areas for
Xaar.
Within the business, the management
team have been proactive in taking steps to manage inflationary
cost pressures, streamlining internal operations, and reducing
overheads. We remain focused on our core technology and the
development of strong customer partnerships as the demand for
digital print capability continues to grow.
Strategic Progress
We believe a significant
opportunity exists in market sectors and applications where Xaar
technology provides commercial and technical performance
advantages. There is a wide range of interest in digital print
across industrial sectors, in particular those using higher
viscosity fluids, and the economic benefit of doing so compared to
existing analogue techniques reassures us that prospects for the
business remain significant.
Our technology strategy is focused
on developing product functionality and places an emphasis on
delivering attributes that customers tell us they need, and our
operational and commercial strategies are designed to make doing
business with Xaar straight forward and cost efficient.
Our vertical integration strategy,
which concentrates on developing competence beyond the printhead
itself into electronics, fluid management and integration, is also
helping us gain access to new applications and is an advantage we
can offer our OEM customers to enable their swift deployment of the
print system element within their products.
As previously announced, we have
invested in our manufacturing facilities to improve efficiency and
lower costs and the first phase of this programme was completed in
early 2023 on time and under budget. This has also enabled
increased capacity and generated cost savings, especially in
reducing our power usage.
Our financial strategy is aimed at
generating strong returns, while maintaining capital discipline and
delivering strong cash generation to facilitate continued
investment in technology, products and capability.
While there is no doubt that the
macro-economic challenges have slowed growth, we are pleased with
the progress we have made across several areas of the business this
year and we have a significant pipeline of opportunities to build
upon in 2024 and beyond.
Financial Results
In a year where inflation and
interest rate increases have dominated the economic landscape, the
Group delivered revenue of £70.6 million (2022: £72.8 million) and
pre-tax profit, adjusted for non-recurring costs, of £2.9 million,
slightly ahead of the prior year. The full year unadjusted loss was
£2.2 million (2022: £0.8 million profit).
Our balance sheet is sound, and we
remain cash positive with banking facilities undrawn. The Group has
maintained higher levels of inventory over the past two years to
mitigate both cost increases and disruption in the supply chain. We
anticipate normalising inventory and gaining the associated
positive cash benefit during 2024.
The Board has not declared a
dividend in 2023 as we continue to believe that prioritising cash
for investment in the business will deliver more compelling returns
for shareholders in the medium term.
People and ESG
A highlight of the year was our
successful application for accreditation as a Great Place to Work.
People are at the heart of Xaar and we prioritise staff
safety and well-being alongside business performance and delivery.
The Board engages with staff representatives regularly and we
remain encouraged by the commitment and energy we see in action
every day. On behalf of the Board, I would like to thank our entire
team for their hard work and diligence.
We also seek to have a wider
positive impact on society by understanding and prioritising
stakeholder needs, managing our business responsibly, and reaching
out to our local communities. Our teams have continued to support
national STEM initiatives, encouraging young people to develop an
interest in technology and business.
A focus on the environment is also
important at Xaar as we make progress towards our goal of net zero
by 2030. Recently we were nominated as finalists at the Edie awards
for Green Project of the Year in relation to our factory
re-organisation project. In addition to in-house initiatives, our
products are designed to be cleaner, more efficient and generate
less waste than traditional print techniques. Our development of
printheads capable of reliable performance using water-based fluids
is a particular area of focus. There is a clear environmental
advantage in using our products as we can print highly viscous
fluids, not just water based, which require much less drying time,
thereby reducing significant energy usage as well as reduced water
content.
Board and Governance
During the year Chris Morgan stood
down from the Board and we welcomed two new non-executive Directors
Richard Amos and Jacqui Sutton.
Richard Amos joined in June 2023
and is the Chair of Audit Committee. Richard also sits on the
Nomination and Remuneration Committees. Jacqui Sutton joined the
Board in November 2023 and sits on the Audit, Nomination and
Remuneration Committees. Both Richard and Jacqui bring a wealth of
experience and have relevant knowledge and skills from their
previous executive and non-executive roles.
In February 2024, Stuart Widdowson
joined the Board as a non-executive Director. Stuart is appointed
as a representative of Odyssean Capital LLP where he is the
Managing Partner.
In a further change, Alison Littley
has notified the Board of her intention to step down as a
non-executive Director during 2024. Alison will stand for
re-election this year but will resign from the board once her
replacement is recruited. An announcement, including arrangements
for chairing the remuneration committee and the senior independent
director role, will be made in due course. I have appreciated
the support of both Alison and Chris Morgan over the years and
would like to take this opportunity to express thanks to them both
for their commitment and contribution to the business.
Looking Ahead
Having put in place strong
foundations through the development of our strategy over the last
three years, the Board is optimistic about the opportunities that
lie ahead for the Group and for all our stakeholders including
employees, customers, and shareholders.
Xaar remains in a good position
with unique and compelling products and a significant addressable
market. External factors mean we are cautious about the short
term, but we believe the business is well positioned for growth
over the medium and long term.
We look forward with
confidence.
Andrew Herbert
Chairman
26 March 2024
Strategy Update
Introduction
2023 was a year in which the Group
delivered encouraging progress in key strategic areas despite
unexpected challenges.
The Group entered 2023 having
invested in inventory over the previous two years to maintain
customer service levels during the period of exceptional supply
chain disruption in 2022, to mitigate cost inflation and to be well
positioned for several customer product launches.
Due to current geo-political and
macro-economic conditions, OEM machine launches are taking longer
than expected which had a significant impact in Q4 of 2023. Several
of these launches were delayed, impacting revenue in the latter
stage of the year and the start of 2024. However, we remain
optimistic about the future, and we are well placed to benefit as
trading conditions improve.
The disappointing end to the year
masked some more encouraging signs. We continue to enjoy leading
positions in attractive structural growth markets. We deepened our
relationships with key customers helped by our widening product
range, and we have grown our customer base and maintained our
market share.
Strategic progress
Xaar delivered a good performance
in 2023. We continue to execute our strategy of delivering
compelling products in each of our market segments and remain
focused on the significant opportunities that will drive profitable
growth.
Our products, especially Aquinox,
are generating strong interest from both existing and new customers
underlining our leadership in jetting highly viscous fluids which,
alongside other advantages, provide significant sustainability
benefits, as well as reducing our customers' time to
market.
We have seen an increase in the
number of customers adopting Xaar technology and we now have
clearer visibility of their product launches. This is evidenced by
the twelve new customer product launches during 2023.
We expect an increase in
customer product launches that incorporate Xaar's technology during
2024, which we anticipate will drive demand for
printheads.
Phase 1 of our factory upgrade has
been successfully completed on time and within budget, positioning
us to deliver increased efficiency and capacity, whilst realising
significant cost savings. Further phases of development will see
increased modernisation of our manufacturing facilities leading to
greater efficiencies and scale potential. These will only be
undertaken when business performance and market conditions
improve.
We have seen continued good
performance from EPS, FFEI and Megnajet, with EPS especially
continuing to deliver excellent revenue and profit growth.
As part of our strategic decision to consider
options to withdraw from the Life Science part of FFEI, we sold
non-core IP assets in the year delivering a profit of £2.0
million.
Financial performance
We have delivered performance in
2023 in line with updated management expectations, demonstrating
operational and strategic progress across the Group. Revenue for
the period was £70.6 million representing a decrease of 3% against
2023.
The Printhead business has a clear
customer-focussed strategy, and we are pleased to have grown our
customer base and at least maintained our market share in key
sectors. The economic challenges globally, particularly rising
interest rates, have directly impacted capital equipment purchases
by some customers in the year, particularly so in Q4
2023.
As a result of these pressures,
revenue for the Printhead business was down 5%. The external
pressures not only impacted customers' new product launches but
also existing core markets for printheads, with the ceramics sector
being particularly affected, linked to the slowdown in the global
construction industry.
Progress has been made in market
sectors beyond Ceramics, especially the key growth area of 3D
printing, and we continue to see strong
customer engagement where we have a competitive advantage enabling
customers' use of high viscosity fluids.
Geographically we delivered growth
in Asia, when compared to the COVID-19 impacted period in 2022.
This increase of £4.0 million (49%) was offset by lower revenue in
the US (down £5.6 million, 15%) and EMEA (down £0.6 million, 2%).
While disappointed with revenue decline in some markets, we are
pleased with the broader spread of business across geographic
regions and market sectors. This demonstrates the increasing
resilience of the business. We have increased diversification
of customers, applications and geographies as the customer pipeline
continues to grow.
EPS has delivered an excellent
performance. Revenue increased 13%, with growth across all its
product lines, and digital inkjet sales at the core of the success
growing 15%. The proactive decisions taken in the last two years to
strengthen the management team and rationalise the product range
are delivering excellent results.
FFEI and Megnajet continue to
perform well. These businesses provide us with an expanded product
range enabling real traction and opportunity in the printbar and
print engine markets, along with fluid management
systems.
Our plan has been to focus on
products that support our core strategy. As a result, we are
considering options to withdraw from the non-core Life Sciences
part of the FFEI business, and the sale of IP in this area during
the year is part of this process. We delivered a one-off profit of
£2.0 million through this sale which helped offset the one-off
impact of Phase one of our factory re-organisation at Huntingdon
completed in Q1.
Gross margin for the Group was 38%
(2022: 39%) despite inflationary cost pressures and closing the
Huntingdon factory for two months to complete Phase 1of the
operational re-organisation. We have successfully protected our
gross margins from input cost inflation which was evident in our
supply chain in 2023. Our ability to pass on inflation increases
underlines the strength of our products and our market
position.
Group adjusted profit before tax
for 2023 was £2.9 million, an increase of £0.1 million when
compared to £2.8 million in 2022. The full
year unadjusted loss was £2.2 million (2022: £0.8 million
profit).
Healthy balance sheet and
operational investment
The Group retains a healthy balance
sheet and cash position. Cash at 31 December 2023 was £7.1 million,
reflecting a net outflow of £1.4 million over the year.
During the year we invested £2.1
million in inventory allowing the Printhead business to increase
its holding of finished goods. This has been a controlled and
systematic approach over the last eighteen months giving confidence
in our ability to deliver on customer orders.
As a consequence of the unexpected
reduced demand in our core markets and particularly a significant
slowdown in the ceramics sector in Q4 2023, we have a higher than
planned finished goods holding in the Printhead
business.
Whilst we have won business through
the advantage of offering shorter lead times than our competition,
ensuring we have been able to capitalise on commercial
opportunities, we continue to monitor the product mix of finished
goods to ensure it is appropriate for customer demand.
Consequently, we expect to reduce inventory levels during 2024
which will have a positive impact on cash generation during the
year.
We will maintain our disciplined
approach to balance sheet management, as it remains a key priority
to allow for further investment in the business focussing on
operational capability. We have been disciplined in our management
of cash expenditure focusing on improving operational capability
and efficiencies, investing £1.5 million (2022: £2.4 million) in
operational upgrades along with the factory upgrade completed in
March 2023.
R&D investment is critical to
the ongoing success of the business, and we will continue to invest
in our R&D capabilities across the Group to ensure our
technology remains market-leading. During 2023 we invested £5.6
million (2022: £6.7 million).
In June 2023 we successfully agreed
a Revolving Credit Facility (RCF) of £5.0 million with our lead
bank, HSBC, which allows for accelerated investment in the business
and our operational capability.
Operational improvements driving greater efficiency and
capacity
Operational improvements have been
made through investment in our manufacturing facilities to increase
efficiency and lower costs. The first phase of this programme has
now been completed with the Huntingdon factory re-organisation
completed in early 2023 on time and under budget.
This will enable us to operate more
efficiently, increase capacity and yields whilst crucially
generating significant cost savings, especially in reducing our
energy consumption. Accordingly, this investment will deliver a
rapid return and payback in less than a year.
This is the first phase of our
efficiency upgrade programme. The next phase of investment will
result in more modern, efficient, and environmentally beneficial
manufacturing facilities across the business. This will be
undertaken when business performance improves, depending on
business needs and volume demand. It is anticipated between £10
million and £15 million will be invested in the next
phase.
We continue to exercise tight
control over our cost base whilst also seeking opportunities to
drive performance. This includes establishing an internal project,
named Hubble, which will provide focus for our key priorities and
goals.
This project is split into 4 key
streams:-
·
Commercial strategic opportunities
·
Operational efficiency
·
Organisational effectiveness
·
Customer integration
Each project stream has an
appropriate Executive sponsor and project lead. The project aims to
deliver cost savings on an annual basis of £2 million of which £1.2
million has already been identified and implemented. The project
will be delivered with no incremental investment.
Significant market opportunity remains
We have a strong proposition across
our five key market sectors. Our digital inkjet technologies
provide compelling propositions to transform print processes across
a wide range of applications, and we can supply our customers with
the products they need to develop their printers. This means we
have significant growth opportunities, incremental to printhead
sales, where we can shorten our customers' product development time
to market.
The medium and long-term
opportunity for the business remains significant. Whilst we already
have good market share in core, mature markets such as Ceramics and
Coding & Marking, our market leading technologies provide
further growth opportunities in applications where our capabilities
offer competitive advantage.
During 2023 we have made
significant progress in 3D printing, where our ability to print
high viscosity fluids is transforming the industry. The 3D printing
sector is experiencing a greater level of customer product
launches, thereby providing greater revenue potential opportunity
for our products than previously expected.
Historically Xaar has almost
exclusively operated in the B2B (Business to Business) area across
our product ranges and applications, however there is an emerging
opportunity for 3D printing in the B2C (Business to Consumer)
sector where we can facilitate growth.
We are partnering with established
system providers for our Xaar Irix printhead to enable a new
generation of full colour, inkjet-based desktop 3D printing systems
that are higher resolution and more flexible than the existing
technologies. We anticipate this new generation of 3D printers to
be launched during 2024 and 2025.
Customer engagement has increased
as our printhead product range has expanded. Our ability to
offer a broader solution to customers with fluid management systems
and printbars has increased the number of customers developing
machines with our products. During 2023 there were twelve customer
product launches, and we anticipate at least a further twelve
launches during 2024.
By providing an integrated solution
for customers whereby they can access more of the printing
ecosystem, we help our customers take advantage of the inkjet
opportunity. Working with Xaar means a higher chance of success by
being faster to market and increasing return on investment.
Ultimately this will help us in our overriding strategy to sell
more printheads and enables the business to manage volatility
better, in any given market.
We are further supporting our
business model with three key initiatives.
Firstly, we are diversifying the
geographical spread of our customer base. By targetting OEMs in
Europe and US, we gain greater regional diversity and reduce our
dependence on any specific region. This has resulted in growth of
new development projects in those regions and will build further
resilience into our business.
The second initiative is to develop
relationships with our end customers in a way that hasn't been
previously achieved. By engaging with end users - in partnership
with our OEMs - we are expanding our market understanding. This not
only strengthens the relationship with end users and direct
customers but presents us with a clear picture of the decisions
that drive the adoption timing of new systems with Xaar
technology.
The transition to Xaar technology
and revolutionary high viscosity inks can present technical
challenges when customers integrate our printheads into a new
system. To counter this we are developing our service offering to
better support them, which is our third initiative. This involves
focussing our resources to identify issues earlier and provide more
direct support to resolve technical challenges. Additionally, we
are developing a full printer solution in house for our key markets
so that we can identify and resolve issues with system integration
before they create problems in the field.
Product development and capability
We have a unique roadmap of product
development to ensure we offer an increasingly vertically
integrated commercial strategy to capitalise on this market
opportunity.
Our Xaar 2002 printhead has double
the resolution of our competitors giving the ability for very
high-quality print and incorporates our key technologies which
enable printing of very challenging fluids in harsh production
environments.
The Xaar Irix remains the flagship
product in the Coding and Marking and Direct-to-Shape sectors. It
delivers increased throw distance whilst maintaining print quality
and along with our Xaar 50X printheads means we are maintaining our
position in Coding and Marking and have several opportunities in
the Direct-to-Shape market.
The Aquinox printhead is positioned
to drive adoption in Packaging and Textiles markets. The response
to the product has been extremely positive due to its ability to
print high viscosity water-based inks. This gives customers the
opportunity to use less energy, with a higher throughput, and more
vibrant colours.
The significant benefits of high
viscosity inks have also recently been independently validated by
the Welsh Centre for Printing at Swansea University confirming the
superiority of our technology. This was demonstrated at our first,
and well-received, R&D open day held in November 2023 which was
attended by customers, commercial partners and potential technology
adopters. They were able to witness and participate in live
demonstration of the functionality that our products offer. The day
was highly successful, demonstrated by the level of interest and
further enquiries we have had since.
The already successful ImagineX
platform will deliver improved features over the next few years
which will provide significant enhancements to the current
portfolio, including:
·
substantially improved speed and throughput
(frequencies up to 150kHz, equivalent to a threefold increase in
speed compared to current products),
·
increased throw distance to improve image quality
on curved surfaces,
·
increased robustness to improve the life of the
printhead and maintain image quality,
·
higher viscosities enabling a broader range of
fluids to be printed (above 100cP), and
·
higher resolutions (up to 1440 dpi).
These features will help strengthen
our position in markets where we are already well represented and
will drive improved adoption in several markets where we are
currently not participating. The enhancements in our product
roadmap support our customers with a clear path to upgrade their
products and maintain their product differentiation.
Strong commitment to sustainability
We continue to make progress on ESG
and the Group's Sustainability Roadmap. The Board remains committed
to the business becoming carbon net zero by 2030.
We are passionate about delivering
solutions and products for our customers that are cleaner and
better for the environment. Our products are well placed to deliver
significant benefits commercially and environmentally for our
customers through reductions in power consumption and water
usage.
Digital inkjet printing is
inherently more sustainable compared to traditional analogue
printing with a smaller carbon footprint. It reduces and prevents
excessive waste and uses less energy due to the ability to print
short runs or direct-to-shape. With Ultra High Viscosity Technology
and TF (ThroughFlow) Technology ink recirculation, Xaar printheads
are capable of printing very viscous fluids which, in the textiles
sector for example, results in a reduction in energy used in
intensive drying processes. We are passionate about continuing
further adoption and understanding of the environmental benefits
our products can bring to customers.
During 2023 we gained full
accreditation for the Great Place To Work certification. This was
especially pleasing as it was gained on our first application and
is testament to the hard work and engagement of colleagues across
the business.
We also seek to have a wider
positive impact on society by understanding and prioritising
employee needs, doing business responsibly, and reaching out to our
local communities. All our UK sites have now moved to 100%
renewable energy. All printhead product packaging is fully
recyclable. Our Apprentice Programme is well developed across the
business, and we continue to support activities promoting STEM
(Science, Technology, Engineering and
Maths) subjects amongst young people as well as several sponsorship
programmes supporting university students and industry
placements.
Outlook
Whilst the end of 2023 was
challenging, and the current external trading environment remains
so, we are focused on the delivery of our strategy and taking
advantage of the significant opportunities we have that will drive
profitable growth. Our products continue to generate strong
interest from customers, demonstrating our leadership in printing
highly viscous fluids with all the performance and sustainability
benefits they deliver.
As previously announced in our
November 2023 trading update, due to the current geo-political and
macro-economic conditions, bringing some of our customer's products
to market is taking longer than expected, meaning we are cautious
on precise timing.
As we reduce our finished goods
inventory during 2024, the lower volumes will impact our ability to
recover production overhead costs. Together with the effect of
increased input costs, as previously explained, our gross margin
will be impacted this year.
Despite this, we will continue to
take decisive action to manage our costs and maximise cash
generation during this slower trading period whilst preserving our
sources of long-term competitive advantage.
We are confident that our market
position remains strong and that the Group remains well positioned
to prosper as our key markets resume a trajectory of healthy
long-term growth. So, despite the short-term challenge we remain
hugely excited for the future of Xaar and remain confident that the
unique capabilities of our printheads will drive broad adoption
across all markets over the coming years.
We believe the business is well
positioned for growth through both new applications and share gains
in new and existing markets and our expectations for the full year
remain unchanged.
Business Performance
Revenue
Despite trading conditions
becoming more challenging in the latter part of the year, the Group
achieved revenue of £70.6 million, representing a marginal £2.2
million (3%) decline on 2022 revenues of £72.8 million. Group
revenues were £34.5 million in the first half of the year and £36.1
million in the second half.
Whilst a lack of growth is
disappointing, underlying market demand remains and we have
retained market share. Therefore, we are confident in the medium
term of returning to previous levels of organic growth. The
pipeline of anticipated customer product launches in the coming
twelve to eighteen months drives this confidence.
Revenue generated by the Digital
Imaging operating segment totalled £8.7 million in the year (2022:
£11.6 million), representing a decline of 25% compared to the prior
year. In accordance with previous statements, as part of the
ongoing integration this year, we have maintained
focus on the core print systems activities acquired and commenced
the strategic exit from the non-core Life Sciences activities that
also formed part of the acquired business. This has resulted in an
aggregate reduction in revenue whilst synergies are built in core
activities.
The year ended 31 December 2023
represents the first full year of trading in the Ink Supply Systems
operating segment following the Group's entrance into this market
in Q1 2022 via the acquisition of Megnajet Limited.
Group revenue by
geographic region
£m
|
FY 2023
|
FY
2022
|
Variance
|
Variance
%
|
|
PH
|
PPS
|
DI
|
ISS*
|
Total
|
PH
|
PPS
|
DI
|
ISS*
|
Total
|
PH
|
PPS
|
DI
|
ISS*
|
Total
|
PH
|
PPS
|
DI
|
ISS*
|
Total
|
Americas
|
8.0
|
19.0
|
3.0
|
0.6
|
30.6
|
10.8
|
19.3
|
4.8
|
1.3
|
36.2
|
(2.8)
|
(0.3)
|
(1.8)
|
(0.7)
|
(5.6)
|
(26)%
|
(2)%
|
(38)%
|
(54)%
|
(15)%
|
Asia
|
8.4
|
3.0
|
0.1
|
0.7
|
12.2
|
7.5
|
0.2
|
0.1
|
0.4
|
8.2
|
0.9
|
2.8
|
-
|
0.3
|
4.0
|
12%
|
1400%
|
-
|
75%
|
49%
|
EMEA
|
20.7
|
0.1
|
5.6
|
1.4
|
27.8
|
20.7
|
0.1
|
6.7
|
0.9
|
28.4
|
-
|
-
|
(1.1)
|
0.5
|
(0.6)
|
-
|
-
|
(16)%
|
56%
|
(2)%
|
Total
|
37.1
|
22.1
|
8.7
|
2.7
|
70.6
|
39.0
|
19.6
|
11.6
|
2.6
|
72.8
|
(1.9)
|
2.5
|
(2.9)
|
0.1
|
(2.2)
|
(5)%
|
13%
|
(25)%
|
4%
|
(3)%
|
* Megnajet Limited was acquired on 2
March 2022 - comparative figures in the table above reflect ten
months of post-acquisition revenue.
PH - Print-head
DI - Digital Imaging ISS - Ink
Supply Systems
Whilst the Americas remains the
Group's primary geographical market representing 43% of total Group
revenue (2022: 50%), revenue from the Americas experienced a
decline of £5.6 million (15%) year-on-year, due to a £2.8 million
reduction in printhead revenue primarily in the Coding &
Marking (C&M) sector, and a £1.8 million reduction in Digital
Imaging revenue.
These reductions in revenue were
partially offset by increased income generation from customers in
Asia, with revenue increasing by £4.0 million to total £12.2
million for the year. This was driven by single-pass machine sales
in Asia by EPS.
Revenue generated from customers
located in EMEA regions remained largely stable year-on-year at
£27.8 million (2022: £28.4 million) which
is pleasing and reflects continued customer engagement across our
product offering in recently entered market sectors.
Printhead revenue
by
sector (Figures (£m)
and percentages
(%) are
subject to
rounding)
|
|
£m
|
2023
H1
|
2023
H2
|
FY 2023
|
FY 2022
|
Var
|
Var %
|
Ceramics
and Glass
|
8.0
|
7.5
|
15.5
|
17.0
|
(1.5)
|
(9)%
|
C&M and DTS
|
5.1
|
6.1
|
11.2
|
12.6
|
(1.4)
|
(11)%
|
WFG
and Labels
|
1.7
|
1.9
|
3.6
|
4.8
|
(1.2)
|
(25)%
|
3D
Printing and AVM
|
2.6
|
3.8
|
6.4
|
3.9
|
2.5
|
64%
|
Packaging
and Textiles
|
0.2
|
0.2
|
0.4
|
0.5
|
(0.1)
|
(20)%
|
Royalties,
Commissions and Fees
|
-
|
-
|
-
|
0.2
|
(0.2)
|
(100)%
|
Total
|
17.6
|
19.5
|
37.1
|
39.0
|
(1.9)
|
(5)%
|
|
|
Whilst COVID-19 restrictions in
China have now been lifted, a trailing impact on demand is still
being suffered by the Group within the
Printhead segment. Suppressed demand has been exacerbated by the
impact of inflationary cost pressures and interest rate rises on
capital equipment sales globally. These constraints on demand have
translated into a £1.9 million (5%) year-on-year reduction in
Printhead revenue.
Growth has been achieved again
this year in the 3D Printing and Advanced Manufacturing (AVM)
sectors, which is pleasing as this reflects our overall customer
strategy and enhanced product portfolio. The 3D printing market
remains an exciting opportunity for us and is a sector we continue
to expect to grow significantly in the future. Revenue from 3D
Printing and AVM grew £2.5 million (64%) year-on-year. Both 3D
Printing and AVM are markets where we are well positioned to take
advantage of growth opportunities and although OEM machine
development cycles can be long, which means extended timescales for
a customer to reach full production, the market opportunity is
significant.
As anticipated, revenue in the
Ceramics and Glass market has reduced, due to the significant
slowdown in the sector, with growth of 9% fall in the
year.
Coding and Marking (C&M) and
Direct-to-Shape (DTS) revenues declined by £1.4 million (11%) in
the year. Revenue from the Wide Format Graphics (WFG) and Labels
market fell 25% in the year from £4.8 million to £3.6 million.
Challenges faced with customer deferrals of orders in the prior
year have continued to postpone revenue recognition for the
Group.
Revenue from Packaging and Textiles continues to be modest. Our ability to
target this sector effectively has been somewhat limited by our
product range, although the launch of the Aquinox printhead has
started to address this. However, advancements in the product
portfolio driven by the ImagineX platform should make this large
sector more accessible in the future. Full year revenue has
remained consistent year-on-year at £0.5 million.
Product Print Systems revenue
by
sector
|
|
£m
|
2023 H1
|
2023 H2
|
FY 2023
|
FY 2022
|
Var
|
Var %
|
|
Digital
Inkjet
|
7.3
|
7.0
|
14.3
|
12.4
|
1.9
|
15%
|
|
6.7
|
0.3
|
4%
|
|
Pad
Printing
|
3.0
|
4.0
|
7.0
|
|
Other
|
0.4
|
0.4
|
0.8
|
0.5
|
0.3
|
60%
|
|
Total
|
10.7
|
11.4
|
22.1
|
19.6
|
2.5
|
13%
|
|
|
|
Figures (£m) and percentages (%) are subject to rounding.
Revenue from the Product Print
Systems business achieved another year of significant growth of
£2.5 million (13%) in 2023, totaling £22.1
million (2022: £19.6 million) for the year. Growth has again been
achieved across all product groups this year, predominantly in the
core area of digital inkjet machine sales, which have grown by £1.9
million (15%). This is particularly welcome seeing as this is the
core focus in this segment and will drive increased
profitability.
The anticipated full year increase
in Pad Printing Machine revenue has been achieved. We see a
strengthening demand pipeline due to the easing of the backlog of
customers' deferred investment in capital equipment and we are well
placed to deliver further growth in 2024.
The change in commercial strategy, increasing focus on
consumables and accessory sales has also contributed to the revenue
growth seen in this segment, with increased revenue (60%) achieved
from ink, plates and parts sales.
Gross profit
The Group maintained a consistent
gross profit margin of 38% (2022: 39%), with gross profit reducing
to £26.9 million (2022: £28.6 million) in line with the reduction
in revenue in the year. The margin structure across all the Group's
operating segments has remained stable year-on-year, cemented by
the actions taken in prior years to deliver efficiency gains and
secure raw material cost-savings to support gross
margin.
The impact on profitability
resulting from the temporary suspension of activity at the Group's
production facility in Huntingdon (the first phase of the Group's
efficiency upgrade programme) was largely successfully mitigated by
the improvements in overhead recovery gained as a consequence of
the resultant increased throughput following the production
facility reorganisation.
Research and development expenses
The Group maintained its R&D
spend to revenue ratio in the desired region of 8-11% with gross,
pre-tax investment in R&D totalling £5.6 million for the year
(2022: £6.7 million). This underscores the Group's continued
commitment to the strategic goal of offering customers a fully
vertically integrated product offering within all product sectors
as set out in the Group's product roadmap; with focus in the year
having been on the ImagineX platform.
We will
continue to invest in our R&D capabilities across the Group to
ensure our technology remains market leading.
Operating expenses
There has been a strong focus on
the management of costs across the Group in response to broader
macro-economic conditions and the headwinds faced in the trading
environment in which the Group is operating.
Sales and marketing spend for the
year of £5.4 million represents a 19% reduction on prior years
(2022: £6.7 million), demonstrating the Group's focused, targeted
approach to managing these costs.
General and administrative
expenses of £20.2 million were £5.7 million higher than the prior
year (2022: £14.5 million). Of this increase, £3.1 million arose
from adjusting items resulting from restructuring and integration
activities.
The remaining £2.6 million
year-on-year increase in adjusted general and administrative
expenses was broadly offset by the £2.2 million increase in other
operating income. This was predominantly generated on disposal of
the intangible assets associated with the non-core Life Sciences
activities in the context of the ongoing integration of the FFEI
Limited business during the year (2023 £2.2 million, 2022: £0.1
million).
Total adjusting items affecting
the operating result were £5.3 million (2022: £2.0 million). Of the
total £3.3 million year-on-year increase, £1.6 million was driven
by unfavorable movements in exchange rates and fair value
measurement. A further £1.0 million of this increase compared to
the prior year was driven by increased spend on restructuring and
efficiency upgrade programmes. Finally, a further £0.4 million
increase in adjusting items resulted from
the ongoing integration of previously acquired
businesses.
Result for the year
The total reported result for the
year consisted of a loss before tax of £2.4 million (2022: profit
before tax of £0.8 million). All of which resulted from continuing
operations and is attributable to the owners of the Group.
Consequently, basic (loss)/earnings per share was
(2.8)p (2022: 2.1p).
After factoring in the impact of
adjusting items, the Group achieved an adjusted profit before tax
of £2.9 million (2022: £2.8 million). This equates to adjusted,
basic earnings per share of 3.6p (2022: 4.8p). This is a pleasing
result in light of the deterioration in the wider macro-economic
environment and trading headwinds encountered during the
year.
Whilst not being measures defined under IFRS, we believe that the
'adjusted profit before tax' and 'adjusted earnings
per share' measures presented, provide
shareholders with a consistent presentation of the Group's
underlying, operational performance. For full details of the nature
and quantum of items added back as 'adjusting' when calculating
these alternative performance measures, please refer to Note 9 of
the consolidated financial statements.
Cash generation
The Group continued its robust,
disciplined focus on cash, ensuring the maintenance of sufficient
financial resources during the year. The Group holds a healthy cash
balance of £7.1 million as at 31 December 2023 (2022: £8.5
million). This represents a reduction of £1.4 million year-on-year,
which has been driven by planned working capital
investment.
Operating cash inflows, before
movements in working capital, generated during the year were £4.6
million (2022: £6.6 million).
In the context of market
headwinds, we continued a proportionate level of investment in
operational infrastructure and product development in the year of
£1.9 million (2022: £5.4 million). This included maintenance
capital expenditure and the completion of the first phase of the
efficiency upgrade programme (namely the
Huntingdon factory reorganisation) in the first half of the year;
which was delivered on time and on budget.
This now enables us to operate
more efficiently by increasing capacity and yields, whilst
crucially generating significant cost savings, especially in the
form of reduced energy consumption. Accordingly, this investment is
anticipated to deliver a rapid return, with payback expected in
less than a year.
In June 2023, we secured a
Revolving Credit Facility of £5 million with our lead bank, HSBC.
Access to these funds allows for accelerated investment in the
business and in our operational capability. As at 31 December 2023,
no amounts were drawn under this facility.
Healthy balance sheet
The Group has maintained a healthy
balance sheet throughout the year with a consistent net current
assets position of £33.5 million (2022:
£30.0 million).
Non-current assets of £45.5
million decreased by £6.5 million during the year. In line with the
Group's cash focus, there was a £1.6 million reduction in property,
plant and equipment as new purchases were controlled. A £2.8
million reduction in the non-current element of the contingent
consideration receivable resulted from the progression of this
arrangement through its ongoing term. The remaining reduction in
the carrying value of non-current assets being the annual
depreciation and amortisation of assets in line with their useful
economic life for the business.
Current assets increased by £1.3
million from £50.5 million as at 31 December 2022 to £51.8 million.
Working capital balances remained broadly flat year-on-year, with
the £1.9 million (7%) increase in inventory being offset by a
reduction in cash and cash equivalents. The increase in current
assets year-on-year predominantly results from the £1.8 million
increase in the contingent consideration receivable following the
re-aging of this balance based on assessments of the earn-out and
milestone consideration expected to meet the conditions for payment
to the Group during the year ending 31 December 2024.
Non-current liabilities totalled
£7.2 million, following a £3.0 million reduction year-on-year. All
remaining deferred consideration payable in respect of business
combinations from prior years falls due for payment during the year
ending 31 December 2024, reducing the non-current deferred
consideration balance by £2.0 million compared to the prior year.
The balance now being £nil as at 31 December 2023. The remainder of
the reduction in non-current liabilities results from changes in
the average remaining lease term of the Group's lease
portfolio.
Current liabilities of £18.2
million have reduced by £2.3 million compared to the prior year
(2022: £20.5 million). This movement is driven by a £3.6 million
reduction in trade and other payables, which is partially offset by
a £1.0 million increase in amounts borrowed under the Group's
invoice discounting facility.
The business has a clear plan and
strategy which its healthy balance sheet and cash position will
support. There remain external development opportunities which, if
they can expand our capabilities and expertise, we will look to
potentially add to the Group. At present, we are focusing
investment internally to ensure we have the operational capacity
and efficiency to meet future demand, alongside investment in our
product roadmap development.
Dividend
No dividend has been declared in
respect of the year. The Board regularly reviews its capital
allocation policy and believes that
prioritising investment to enable profitable growth for the
business is currently the most appropriate use of capital and is
expected to achieve more compelling medium-term returns for
shareholders.
John Mills
Chief Executive Officer
26 March 2024
|
Ian Tichias
Chief Financial Officer
26 March 2024
|
|
CONSOLIDATED INCOME STATEMENT
|
|
FOR THE YEAR ENDED 31 DECEMBER
2023
|
|
|
|
|
|
|
|
|
|
Year
ended 31 December 2023
|
Year
ended 31 December 2022
|
|
|
Adjusted
|
Adjusting
items
|
Total
|
Adjusted
|
Adjusting
items
|
Total
|
|
Notes
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
Revenue
|
2
|
70,614
|
-
|
70,614
|
72,782
|
-
|
72,782
|
Cost of sales
|
|
(43,723)
|
-
|
(43,723)
|
(44,138)
|
-
|
(44,138)
|
Gross profit
|
|
26,891
|
-
|
26,891
|
28,644
|
-
|
28,644
|
Research and development
expenses
|
4
|
(5,642)
|
179
|
(5,463)
|
(6,718)
|
379
|
(6,339)
|
Sales, general and administrative
expenses
|
4
|
(20,093)
|
(5,484)
|
(25,577)
|
(18,828)
|
(2,377)
|
(21,205)
|
Other income
|
5
|
2,201
|
-
|
2,201
|
139
|
-
|
139
|
Operating (loss) / profit
|
|
3,357
|
(5,305)
|
(1,948)
|
3,237
|
(1,998)
|
1,239
|
Finance income
|
|
89
|
-
|
89
|
38
|
-
|
38
|
Finance costs
|
|
(562)
|
-
|
(562)
|
(453)
|
-
|
(453)
|
(Loss) / profit before tax
|
|
2,884
|
(5,305)
|
(2,421)
|
2,822
|
(1,998)
|
824
|
Tax
|
|
(64)
|
311
|
247
|
867
|
100
|
967
|
(Loss) / Profit for the year from continuing
operations
|
|
2,820
|
(4,994)
|
(2,174)
|
3,689
|
(1,898)
|
1,791
|
Loss from discontinued operations
after tax
|
|
-
|
-
|
-
|
(159)
|
-
|
(159)
|
(Loss) / profit for the year attributable to the equity
shareholder of the parent
|
|
2,820
|
(4,994)
|
(2,174)
|
3,530
|
(1,898)
|
1,632
|
|
|
|
|
|
|
|
|
(Loss)/earnings per share
|
|
|
|
|
|
|
|
Basic
|
3
|
3.6p
|
|
(2.8)p
|
4.8p
|
|
2.1p
|
Diluted
|
3
|
3.5p
|
|
(2.8)p
|
4.5p
|
|
2.0p
|
|
|
|
|
|
|
|
|
|
|
|
* Further information on adjusting items is
included in Note 4
CONSOLIDATED STATEMENT OF COMPREHENSIVE
INCOME
FOR THE YEAR ENDED 31 DECEMBER
2023
|
|
|
|
|
|
|
|
|
|
|
|
Year ended
31 December
2023
|
Year
ended
31
December
2022
|
|
|
|
|
|
£'000
|
£'000
|
(Loss) / profit for the year attributable to the equity of
the shareholder of the parent
|
|
|
|
|
(2,174)
|
1,632
|
Items that may be reclassified to the income statement in
subsequent years
|
|
Exchange (losses)/gains on
translation of foreign operations
|
|
|
|
|
(318)
|
617
|
Other comprehensive (expense) / income for the
year
|
|
|
|
|
(2,492)
|
2,249
|
Total comprehensive (expense) / income for the
year
|
|
|
|
|
(2,492)
|
2,249
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CONSOLIDATED STATEMENT OF FINANCIAL
POSITION
|
|
AS AT 31 DECEMBER
2023
|
|
|
|
31 December
2023
|
31
December
2022
|
|
£'000
|
£'000
|
Non-current assets
|
|
|
Goodwill
|
6,873
|
7,163
|
Other intangible assets
|
7,366
|
8,681
|
Property, plant and
equipment
|
14,529
|
16,104
|
Right of use asset
|
7,826
|
8,068
|
Financial asset at fair value
through profit or loss
|
8,277
|
11,089
|
Deferred tax asset
|
493
|
726
|
Non-current financial
assets
|
136
|
136
|
|
45,500
|
51,967
|
Current assets
|
|
|
Inventories
|
31,035
|
29,148
|
Trade and other
receivables
|
8,802
|
10,027
|
Contract assets
|
2,156
|
1,500
|
Current tax receivable
|
306
|
735
|
Financial asset at fair value
through profit or loss
|
2,322
|
517
|
Cash and cash
equivalents
|
7,135
|
8,546
|
|
51,756
|
50,473
|
Total assets
|
97,256
|
102,440
|
Current liabilities
|
|
|
Trade and other
payables
|
(9,568)
|
(13,216)
|
Deferred consideration
|
(2,115)
|
(1,646)
|
Provisions
|
(972)
|
(405)
|
Contract liabilities
|
(2,369)
|
(3,799)
|
Borrowings
|
(1,403)
|
(379)
|
Lease liabilities
|
(1,800)
|
(1,032)
|
|
(18,227)
|
(20,477)
|
Net current assets
|
33,529
|
29,996
|
Non-current liabilities
|
|
|
Lease liabilities
|
(6,898)
|
(7,800)
|
Provisions
|
(300)
|
(300)
|
Deferred consideration
|
-
|
(2,094)
|
|
(7,198)
|
(10,194)
|
Total liabilities
|
(25,425)
|
(30,671)
|
Net assets
|
71,831
|
71,769
|
Equity
|
|
|
Share capital
|
7,923
|
7,844
|
Share premium
|
29,950
|
29,427
|
Own shares
|
(566)
|
(775)
|
Translation reserves
|
1,310
|
1,628
|
Other reserves
|
6,256
|
6,256
|
Retained earnings
|
26,958
|
27,389
|
Total equity
|
71,831
|
71,769
|
CONSOLIDATED STATEMENT OF CASH FLOWS
|
|
|
|
FOR THE YEAR ENDED 31 DECEMBER
2023
|
|
|
|
|
|
Year ended
31 December
2023
|
Year
ended
31
December
2022
|
|
Notes
|
£'000
|
£'000
|
Cash utilised by operations
|
6
|
(1,537)
|
(5,617)
|
Net income taxes
received
|
|
1,088
|
112
|
Net cash outflow from operating activities
|
|
(449)
|
(5,505)
|
Investing activities
|
|
|
|
Investment income
|
|
89
|
38
|
Purchases of property, plant and
equipment
|
|
(1,510)
|
(2,456)
|
Proceeds from sale of property,
plant and equipment
|
|
24
|
17
|
Purchases of intangible
assets
|
|
(430)
|
(2,933)
|
Proceeds from sale of intangible
assets
|
|
1,760
|
-
|
Cash earn-out received from
financial assets at FVTPL
|
|
637
|
236
|
Net cash outflow arising from
acquisitions
|
|
-
|
(3,536)
|
Net cash inflow / (outflow) from investing
activities
|
|
570
|
(8,634)
|
Financing activities
|
|
|
|
Proceeds from sale of own
shares
|
|
15
|
408
|
Proceeds from issue of
shares
|
|
602
|
-
|
Payment for own shares
acquired
|
|
-
|
(1,000)
|
Lease payments
|
|
(1,075)
|
(914)
|
Interest paid
|
|
(59)
|
(22)
|
Utilisation of revolving credit
facility
|
|
1,700
|
-
|
Repayment of revolving credit
facility
|
|
(1,700)
|
-
|
Net inflows from invoice
discounting facility
|
|
915
|
346
|
Payment of deferred
consideration
|
|
(1,746)
|
(1,733)
|
Net cash outflow in financing activities
|
|
(1,348)
|
(2,915)
|
Net decrease in cash and cash equivalents
|
|
(1,227)
|
(17,054)
|
Cash and cash equivalents at
beginning of year
|
|
8,546
|
25,051
|
Effect of foreign exchange
rates
|
|
(184)
|
549
|
Cash and cash equivalents at end of year
|
|
7,135
|
8,546
|
NOTES TO THE CONSOLIDATED FINANCIAL
INFORMATION
FOR THE YEAR ENDED 31 DECEMBER
2023
1. Presentation of the financial
information
a) Basis of preparation
The financial information, which
comprises the Consolidated Income Statement, Consolidated Statement
of
Comprehensive Income, Consolidated
Statement of Financial Position, Consolidated Statement of Changes
in Equity, Consolidated Cash Flow Statement and extracts from the
notes to the consolidated financial statements for the year ended
31 December 2023, has been prepared in accordance with UK-adopted
International Accounting Standards and in conformity with the
requirements of the Companies Act 2006.
The financial information
incorporates the results of the Company and the entities under its
control (together the 'Group').
The financial information has been
presented in Sterling and has been prepared under the historical
cost convention as modified for the revaluation of certain
financial instruments. All values are rounded to the nearest
thousand pounds (£'000) except when otherwise indicated.
The financial information does not
constitute statutory financial statements within the meaning of
Sections 434 to 436 of the Companies Act 2006. Statutory financial
statements for the year ended 31 December 2022 have been filed with
the Registrar of Companies and those for the year ended 31 December
2023 were approved by the Board of Directors on 25 March 2024 and
will be delivered in due course. The Auditor has reported on the
financial statements for the year ended 31 December 2023 and their
Report was unqualified and did not contain statements under Section
498 (2) or (3) of the Companies Act 2006.
b) Alternative performance
measures
The alternative performance measures
(APMs) used by the Group adjust for both recurring and
non-recurring items that the Directors consider are not reflective
of the underlying performance of the Group. Recurring items are
adjusted each year irrespective of materiality to ensure consistent
treatment.
The Directors believe that the
'adjusted profit before tax' and 'adjusted earnings per share'
measures presented provide a consistent presentation of the Group's
underlying operational performance. They also present shareholders
with a clearer insight of performance metrics used by the Chief
Operating Decision Maker and mitigate volatility, for example
resulting from exchange rate fluctuations, resulting from external
factors that are not influenced by the Group.
These measures are not defined under
IFRS; therefore, they may not be directly comparable with the
'adjusted' profit measures of other companies.
Adjusting items are defined as
follows:
+ fair value gains or losses on
financial assets at FVTPL;
+ restructuring and transaction
expenses;
+ amortisation of intangible assets
arising on business combinations;
+ foreign exchange gains or losses
arising on intra-group transactions;
+ research and development
expenditure credits and patent box tax credits;
+ share-based payments charges and
employer's tax contributions thereon; and
+ the tax effect of the
aforementioned adjusting items.
c) Going Concern
The consolidated financial
statements are prepared on a going concern basis. Having considered
the Group's forecast financial performance and cash flows, and
after making appropriate enquiries, the Directors have a reasonable
expectation that the Group has adequate financial resources to
continue in operational existence for the foreseeable future and
for at least one year from the date that these consolidated
financial statements are signed. For these reasons, they continue
to adopt the going concern basis in preparing the consolidated
financial statements. Accordingly, these financial statements do
not include any adjustments to the carrying amount or
classification of assets and liabilities that would result if the
Group were unable to continue as a going concern.
When making their assessment, the
Directors have considered the impacts on profitability of margin
constraints prompted by inflationary cost pressures. Furthermore,
the impacts on revenue generation and profitability resulting from
wider market disruption in certain customer and supplier markets
and jurisdictions have been factored into forecast and sensitivity
scenarios.
A reverse stress test has been
performed to model the circumstances required to eliminate
available liquidity during the going concern period, this includes
reducing revenues. This reverse stress scenario would require a
reduction in Printhead segment revenue in excess of 23% in
comparison to the base case, which would be below the actual
reported result for the year ended 31 December 2023. The Directors
believe the possibility of this combination of severe downsides
arising to be remote given the recurring revenue base,
predictability of forecasts and new revenue streams secured from
products launched by OEMs in the second half of 2023 or due to be
launched in 2024.
In the unlikely event of such a
scenario materialising, the Group has a range of mitigating
actions, focused on reducing the Group's cost base, that could be
taken to avoid a liquidity shortfall. Namely, deferring
non-committed capital expenditure, delaying, or suspending research
and development expenditure, reducing performance related pay by
aligning payments to actual results and/or ultimately even making
headcount reductions. It is worth noting that such actions would
only be required in the event of an extreme downside
scenario.
The Group is continuously monitoring
and mitigating, where possible, the impacts of such risks. There is
a high degree of predictability within the Group's short-term cash
flows as they reflect existing technologies and products, existing
OEM adoption and the committed order pipeline. The level of
sensitivity testing, and reverse stress testing performed is
proportionate to this level of predictability.
The Group continues to have a net
current assets position and maintained sufficient financial
resources as at 31 December 2023. These consist of cash and cash
equivalents of £7,135,000 as well as £5,000,000 of committed, but
undrawn, banking facilities made available under a revolving credit
facility agreement which currently expires in June 2025. The
revolving credit facility is subject to leverage, interest cover
and capital expenditure threshold covenants. In addition, to
support the Group's working capital position, alongside the above
core banking facilities, the Group also has access to ancillary
funding arrangements in the form of an invoice discounting
facility; of which £1,403,000 of the total £3,000,000 committed
facility was utilised as at 31 December 2023.
2. Operating segments
The Group's operating segments are
determined based on the internal reporting to the Chief Operating
Decision Maker (CODM). The CODM has been determined to be the Chief
Executive Officer, with support from the other members of the Board
of Directors, being the individual who is primarily responsible for
the allocation of resources to segments and the assessment of
performance of the segments.
The principal activities of the
Group are presented in the following segments: 'Printhead',
'Product Print Systems', 'Digital Imaging' and 'Ink Supply
Systems'. This presentation reflects how the Group's operating
performance is reviewed internally by management.
|
Printhead
|
Product Print
Systems
|
Digital
Imaging
|
Ink Supply
Systems
|
Unallocated
|
Total
|
Year ended 31 December 2023
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
Revenue - external
|
37,086
|
22,063
|
8,748
|
2,717
|
-
|
70,614
|
Revenue - intra segment
|
771
|
-
|
-
|
423
|
(1,194)
|
-
|
Adjusted operating (loss)/profit
|
(2,867)
|
3,195
|
2,207
|
822
|
-
|
3,357
|
Adjusting items
|
(1,037)
|
(1,251)
|
(922)
|
(213)
|
(1,822)
|
(5,305)
|
Operating (loss)/profit
|
(3,904)
|
1,944
|
1,285
|
609
|
(1,882)
|
(1,948)
|
|
Printhead
|
Product Print
Systems
|
Digital
Imaging
|
Ink Supply
Systems
|
Unallocated
|
Total
|
Year ended 31 December
2022
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
Revenue - external
|
39,042
|
19,624
|
11,633
|
2,483
|
-
|
72,782
|
Revenue - intra segment
|
1,399
|
-
|
-
|
538
|
(1,937)
|
-
|
Adjusted operating (loss)/profit
|
(626)
|
2,756
|
337
|
770
|
-
|
3,237
|
Adjusting items
|
457
|
-
|
(479)
|
(228)
|
(1,748)
|
(1,998)
|
Operating (loss)/profit
|
(169)
|
2,756
|
(142)
|
542
|
(1,748)
|
1,239
|
3. Earnings per share - basic and
diluted
Basic EPS and adjusted basic EPS are
calculated by dividing the earnings attributable to the equity
shareholders of the Company by the weighted average number of
shares outstanding during the year. Diluted EPS and adjusted
diluted EPS are calculated on the same basis as basic EPS but with
a further adjustment to the weighted average number of shares
outstanding to assume conversion of all potentially dilutive
ordinary shares. Such potentially dilutive ordinary shares comprise
share options and awards granted to employees where the exercise
price is less than the average market price of the Company's
ordinary shares during the year and any unvested shares which have
met, or are expected to meet, the performance conditions at the end
of the year.
The calculation of basic and diluted
earnings per share is based on the following data:
|
Year ended
31 December
2023
|
Year
ended
31
December
2022
|
|
£'000
|
£'000
|
Earnings
|
|
|
Profit attributable to equity
shareholders of the parent - adjusted
|
2,820
|
3,530
|
Adjusting items
|
(4,994)
|
(1,898)
|
(Loss)/profit attributable to
equity shareholders of the parent - reported
|
(2,174)
|
1,632
|
|
|
|
|
Number
|
Number
|
Number of shares
|
|
|
Weighted average number of
ordinary shares in issue
|
78,584,418
|
78,446,230
|
Less: ordinary shares held by Xaar
Trustee Limited and the Xaar Plc ESOP Trust
|
(335,556)
|
(896,966)
|
Weighted average number of ordinary shares for the purposes
of basic EPS
|
78,248,862
|
77,549,264
|
Effect of potentially dilutive
ordinary shares - share options and awards
|
2,613,007
|
4,085,096
|
Weighted average number of ordinary shares for the purposes
of diluted EPS
|
80,861,869
|
81,634,360
|
|
|
|
|
Pence per
share
|
Pence per
share
|
Basic EPS
|
(2.8)p
|
2.1p
|
Diluted EPS
|
(2.8)p
|
2.0p
|
Adjusted Basic EPS
|
3.6p
|
4.8p
|
Adjusted Diluted EPS
|
3.5p
|
4.5p
|
4. Adjusting items
|
|
Year ended
31 December
2023
|
Year
ended
31
December 2022
|
|
|
£'000
|
£'000
|
Share-based payment
charges
|
(i)
|
(1,882)
|
(1,748)
|
Exchange (losses)/gains on
intra-group transactions
|
(ii)
|
(364)
|
811
|
Restructuring and transaction
expenses
|
(iii)
|
(1,501)
|
(450)
|
Research and development
expenditure tax credits
|
(iv)
|
179
|
379
|
Fair value losses on financial
assets at FVTPL
|
(v)
|
(369)
|
(8)
|
Amortisation of intangible assets
arising on business combinations
|
(vi)
|
(1,368)
|
(982)
|
Affecting operating profit and profit before
tax
|
|
(5,305)
|
(1,998)
|
Tax effect of adjusting
items
|
|
311
|
100
|
Affecting tax
|
|
311
|
100
|
Total adjusting items after tax
|
|
(4,994)
|
(1,898)
|
(i) Comprises share-based payment
charges of £1,937,000 (2022: £1,559,000) partially offset by an
accrual release of £55,000 (2022: charge of £189,000) for the
associated employer's social security contributions and are
included in selling, general and administrative
expenses.
(ii) Comprises exchange gains or
losses as a result of intra-group transactions in the United States
of America. Such costs are included in selling, general and
administrative expenses.
(iii) Comprises restructuring costs
of £1,501,000 (2022: £256,000) and acquisition costs of £nil (2022:
£194,000). Restructuring costs include provision for redundancy
costs of £761,000 (2022: £93,000) and £740,000 (2022: £163,000) of
costs resulting from the Group's operational efficiency program.
The prior year acquisition costs relate to the acquisition of
Megnajet Limited. Such costs are included in selling, general and
administrative expenses.
(iv) Comprises UK corporation tax
relief relating to qualifying research and development expenditure.
During the year, £179,000 was claimed of which £15,000 related to
XaarJet Limited and £164,000 related to FFEI Limited for the year
ended 31 December 2023.
During
year ended 31 December 2022, £379,000 was claimed of which £198,000
related to XaarJet Limited's claim for the year ended 31 December
2020 and £219,000 related to FFEI Limited's claim for the year
ended 31 March 2021. These credits are included in research and
development expenses.
(v) Comprises the fair value
movement on contingent consideration that arose on the Group's
divestment of Xaar 3D Limited. Such amounts are included in
selling, general and administrative expenses. Refer to Note 30 for
further information.
(vi) The intangible assets consist
of the software, patents and customer relationships recognised on
acquisition of FFEI Limited in 2021 and the customer relationships
and brand value recognised on acquisition of Megnajet Limited in
2022. These costs are included in selling, general and
administrative expenses.
5. Other operating income
|
|
Year ended 31
December
2023
|
Year
ended
31
December 2022
|
|
|
£'000
|
£'000
|
Profit on disposal of intangible
assets
|
|
2,036
|
-
|
Settlements received
|
|
165
|
-
|
Government grants
|
|
-
|
139
|
Total other operating income
|
|
2,201
|
139
|
In June 2023 the Group entered into
a series of transactions in the context of the integration of the
recently acquired FFEI Limited business. These consisted in part of
the disposal of the non-core Life Sciences activities and all
associated patents, software and technological know-how.
Consideration for the sale of these intangible assets totalled
£2,312,000, generating a profit of £2,036,000 after deduction of
the asset's carrying value. The consideration is receivable in
instalments with £1,760,000 having been received as at 31 December
2023. The remaining £552,000 falls due in the year ending 31
December 2024.
Settlements received constitute
compensation under legal claims.
The Group, through the recently
acquired FFEI Limited, previously received grants under the UK
Research and Innovation 'Future Leaders Fellowships' scheme. Grants
were issued with the aim of increasing the throughput, quality and
validity of imaging data for biomedical artificial intelligence. No
such grant income has been recognised or received during the year
ended 31 December 2023.
6. Note to cash flow statement
|
|
31 December
2023
|
31
December 2022
|
|
|
£'000
|
£'000
|
(Loss)/profit before tax
from:
|
|
|
|
Continuing operations
|
|
(2,421)
|
824
|
Discontinued operations
|
|
-
|
(159)
|
(Loss)/profit before tax including discontinued
operations
|
|
(2,421)
|
665
|
Adjustments for:
|
|
|
|
Depreciation of property, plant
and equipment
|
|
2,914
|
2,654
|
Depreciation of right-of-use
assets
|
|
1,084
|
1,071
|
Amortisation of intangible
assets
|
|
1,487
|
1,067
|
Impairment of property, plant and
equipment
|
|
-
|
147
|
Research and development
expenditure credit
|
|
(179)
|
(379)
|
Net interest expense
|
|
473
|
415
|
Unrealised currency translation
losses/(gains)
|
|
426
|
(797)
|
Payment of cash settled
share-based payments
|
|
-
|
(249)
|
Share-based payment
charge
|
|
1,882
|
1,748
|
Fair value loss on financial
assets at FVTPL
|
|
369
|
8
|
Loss on disposal of property,
plant and equipment
|
|
24
|
80
|
Gain on disposal of intangible
assets
|
|
(2,036)
|
-
|
Increase in provisions
|
|
568
|
141
|
Operating cash flows before movements in working
capital
|
|
4,591
|
6,571
|
Increase in inventories
|
|
(2,057)
|
(9,462)
|
Decrease/(increase) in
receivables
|
|
942
|
(812)
|
Decrease in payables
|
|
(5,013)
|
(1,914)
|
Cash utilised from operations
|
|
(1,537)
|
(5,617)
|